参考文献/References:
[1]Lee E,Han JH,Bang CH,et al.Risk of End-Stage Renal Disease in Psoriatic Patients:Real-World Data from a Nationwide Population-Based Cohort Study[J].Sci Rep,2019,9(1):16581. [2]Shah K,Mellars L,ChangolkarA,et al.Real-world burden of comorbidities in US patients with psoriasis[J].J Am Acad Dermatol,2017,77(2):287-292. [3]Singh NP,Prakash A,Kubba S,et al.Psoriatic nephropathy-does an entity exist[J].Ren Fail, 2005,27(1):123-127. [4]Chiu HY,Huang HL,Li CH,et al.Increased risk of glomerulonephritis and chronic kidney disease in relation to the severity of psoriasis,concomitant medication,and comorbidity:a nationwide population-based cohort study[J].Br J Dermatol,2015,173(1):146-154. [5]Ungprasert P,Raksasuk S.Psoriasis and risk of incident chronic kidney disease and end-stage renal disease:a systematic review and meta-analysis[J].Int Urol Nephrol,2018,50(7):1277-1283. [6]Ren F,Zhang M,Zhang C,et al.Psoriasis-Like Inflammation Induced Renal Dysfunction Through the TLR/NF-κ B Signal Pathway[J].Biomed Res Int,2020(2020):3535264. [7]Li S,Liu Y,He Y,et al.Podocytes present antigen to activate specific T cell immune responses in inflammatory renal disease[J].J Pathol,2020,252(2):165-177. [8]Al-Harbi NO,Nadeem A,Ansari MA,et al.Psoriasis-like inflammation leads to renal dysfunction via upregulation of NADPH oxidases and inducible nitric oxide synthase[J]. IntImmunopharmacol,2017(46):1-8. [9]Podkowińska A,Formanowicz D.Chronic Kidney Disease as Oxidative Stress-and Inflammatory-Mediated Cardiovascular Disease[J].Antioxidants (Basel),2020,9(8):752. [10]Thomas J,Küpper M,Batra R, et al.Is the humoral immunity dispensable for the pathogenesis of psoriasis[J].J Eur Acad Dermatol Venereol,2019,33(1):115-122. [11]Grewal SK,Wan J,Denburg MR,et al.The risk of IgA nephropathy and glomerular disease in patients with psoriasis:a population-based cohort study[J].Br J Dermatol,2017,176(5):1366-1369. [12]Magistroni R,D’Agati VD,Appel GB,et al.New developments in the genetics, pathogenesis,and therapy of IgA nephropathy[J].Kidney Int,2015,88(5):974-989. [13]Takeshita J,Wang S,Shin DB,et al.Effect of psoriasis severity on hypertension control:a population-based study in the United Kingdom[J].JAMA Dermatol,2015,151(2):161-169. [14]Koppe L,Fouque D.The Role for Protein Restriction in Addition to Renin-Angiotensin-Aldosterone System Inhibitors in the Management of CKD[J].Am J Kidney Dis,2019,73(2):248-257. [15]Alba BK,Greaney JL,Ferguson SB,et al.Endothelial function is impaired in the cutaneous microcirculation of adults with psoriasis through reductions in nitric oxide-dependent vasodilation[J].Am J Physiol Heart Circ Physiol,2018,314(2):H343-H349. [16]Garshick MS,Barrett TJ,Wechter T,et al.Inflammasome Signaling and Impaired Vascular Health in Psoriasis[J].Arterioscler Thromb Vasc Biol,2019,39(4):787-798. [17]李雪,解欣然,蒙玉娇,等.银屑病与胰岛素抵抗[J].环球中医药,2019,12(6):972-978. [18]Redon J,Lurbe E.The kidney in obesity[J].Curr Hypertens Rep,2015,17(6):555. [19]Wong Y,Nakamizo S,Tan KJ,et al.An Update on the Role of Adipose Tissues in Psoriasis[J]. Front Immunol,2019(10):1507. [20]Rutkowski JM,Wang ZV,Park AS,et al.Adiponectin promotes functional recovery after podocyte ablation[J].J Am Soc Nephrol,2013,24(2):268-282. [21]Dervisoglu E,Akturk AS,Yildiz K,et al.The spectrum of renal abnormalities in patients with psoriasis[J].Int Urol Nephrol,2012,44(2):509-514. [22]曹璐,张建江,席微波,等.儿童银屑病共病肾损害的临床研究[J].中国妇幼健康研究,2020,31(6):818-822. [23]Yan K,Zhang Y,Han L,et al.Safety and efficacy of methotrexate for Chinese adults with psoriasis with and without psoriatic arthritis[J].JAMA Dermatol,2019,155(3):327-334. [24]Kim BR,Yang S,Doh EJ,et al.Risk factors affecting adverse effects of cyclosporine A in a real-world psoriasis treatment[J].Ann Dermatol,2018,30(2):143-149. [25]Hong JR,Lee YW,Choe YB,et al.Risk factors for increased serum creatinine level in patients with psoriasis treated with cyclosporine in a real-world practice[J].Dermatol Ther,2019,32(3):e12875. [26]Dabak DO,Kocaman N.Effects of silymarin on methotrexate-induced nephrotoxicity in rats[J].Ren Fail,2015,37(4):734-739. [27]Heidari R,Ahmadi A,Mohammadi H,et al.Mitochondrial dysfunction and oxidative stress are involved in the mechanism of methotrexate-induced renal injury and electrolytes imbalance[J].Biomed Pharmacother,2018(107):834-840. [28]Shalaby YM,Menze ET,Azab SS,et al.Involvement of Nrf2/HO-1 antioxidant signaling and NF-κB inflammatory response in the potential protective effects of vincamine against methotrexate-induced nephrotoxicity in rats:cross talk between nephrotoxicity and neurotoxicity[J].Arch Toxicol,2019,93(5):1417-1431. [29]CabelloZurita C,Grau Pérez M,Hernández Fernández CP,et al.Effectiveness and safety of Methotrexate in psoriasis:an eight-year experience with 218 patients[J].J Dermatolog Treat,2017,28(5):401-405. [30]Baker M,Perazella MA.NSAIDs in CKD:Are They Safe[J].Am J Kidney Dis,2020,76(4):546-557. [31]Maghfour J,Elliott E,Gill F,et al.Effect of biologic drugs on renal function in psoriasis patients with chronic kidney disease[J].J Am Acad Dermatol,2020,82(5):1249-1251. [32]Visconti L,Leonardi G,Buemi M,et al.Kidney disease and psoriasis: novel evidences beyond old concepts[J].Clin Rheumatol,2016,35(2):297-302. [33]Corden E,Higgins E,Smith C.Hypercalcaemia-induced kidney injury caused by the vitamin D analogue calcitriol for psoriasis:a note of caution when prescribing topical treatment[J].Clin Exp Dermatol,2016,41(8):899-901. [34]Ohigashi S,Tatsuno I,Uchida D,et al.Topical treatment with 22-oxacalcitriol(OCT),a new vitamin D analogue,caused severe hypercalcemia with exacerbation of chronic renal failure in a psoriatic patient with diabetic nephropathy;a case report and analysis of the potential for hypercalcemia[J].Intern Med,2003,42(12):1202-1205. [35]Braun G,Witt M,Mayer V,et al.Hypercalcemia caused by vitamin D3 analogs in psoriasis treatment[J].IntJ Dermatol,2007,46(12):1315-1317.
相似文献/References:
[1]郑文新,刘 红,汪 伟.银屑病易感基因的生物信息分析[J].医学信息,2018,31(21):1.[doi:10.3969/j.issn.1006-1959.2018.21.001]
ZHENG Wen-Xin,LIU Hong,WANG Wei.Bioinformatics Analysis of the Susceptible Genes of Psoriasis[J].Medical Information,2018,31(06):1.[doi:10.3969/j.issn.1006-1959.2018.21.001]
[2]赵海莲.血尿酸水平与2型糖尿病肾病患者肾脏损害的相关性分析[J].医学信息,2020,33(06):93.[doi:10.3969/j.issn.1006-1959.2020.06.027]
ZHAO Hai-lian.Correlation Between Serum Uric Acid Level and Renal Damage in Patients with Type 2 Diabetic Nephropathy[J].Medical Information,2020,33(06):93.[doi:10.3969/j.issn.1006-1959.2020.06.027]
[3]李小智,丁长松,黄辛迪.基于数据挖掘的中医治疗银屑病临床用药规律研究[J].医学信息,2021,34(01):4.[doi:10.3969/j.issn.1006-1959.2021.01.002]
LI Xiao-zhi,DING Chang-song,HUANG Xin-di.Research on the Law of Clinical Use of Traditional Chinese Medicine for Psoriasis Based on Data Mining[J].Medical Information,2021,34(06):4.[doi:10.3969/j.issn.1006-1959.2021.01.002]
[4]熊戌霞,蔡梦珊,吴文钦.血清鳞状细胞癌抗原在常见皮肤病中的检测价值[J].医学信息,2021,34(17):181.[doi:10.3969/j.issn.1006-1959.2021.17.050]
XIONG Xu-xia,CAI Meng-shan,WU Wen-qin.The Value of Serum Squamous Cell Carcinoma Antigen Detection in Common Skin Diseases[J].Medical Information,2021,34(06):181.[doi:10.3969/j.issn.1006-1959.2021.17.050]
[5]谢 晗,曾同祥.IL-17在常见皮肤病中的作用[J].医学信息,2021,34(23):33.[doi:10.3969/j.issn.1006-1959.2021.23.009]
XIE han,ZENG Tong-xiang.Role of IL-17 in Common Skin Diseases[J].Medical Information,2021,34(06):33.[doi:10.3969/j.issn.1006-1959.2021.23.009]
[6]任静静,石 瑛,智艳芳,等.基于生物信息学分析筛选银屑病的关键基因[J].医学信息,2022,35(24):1.[doi:10.3969/j.issn.1006-1959.2022.24.001]
REN Jing-jing,SHI Ying,ZHI Yan-fang,et al.Screening of Key Genes in Psoriasis Based on Bioinformatics Analysis[J].Medical Information,2022,35(06):1.[doi:10.3969/j.issn.1006-1959.2022.24.001]
[7]吴思琪,吕 健,席俊羽,等.冰黄肤乐软膏治疗银屑病的有效性和安全性的Meta分析[J].医学信息,2023,36(11):43.[doi:10.3969/j.issn.1006-1959.2023.11.008]
WU Si-qi,LYU Jian,XI Jun-yu,et al.Meta-analysis of the Efficacy and Safety of Binghuang Fule Ointment in the Treatment of Psoriasis[J].Medical Information,2023,36(06):43.[doi:10.3969/j.issn.1006-1959.2023.11.008]
[8]黄 永,顾礼忠.NB-UVB与白芍总苷胶囊联合用于银屑病患者治疗对免疫功能及皮损PASI评分的影响[J].医学信息,2023,36(12):148.[doi:10.3969/j.issn.1006-1959.2023.12.030]
HUANG Yong,GU Li-zhong.Effect of NB-UVB Combined with Total Glucosides of Paeony Capsule on Immune Function and PASI Score of Psoriasis Patients[J].Medical Information,2023,36(06):148.[doi:10.3969/j.issn.1006-1959.2023.12.030]